Harvard is still one of the most richly funded research universities in the world. Although much of its available monies come from private foundations and donations, Harvard also draws millions of dollars annually in government sponsored research. The 2014 most recent stats are listed below:
Researchers at the University of Massachusetts Amherst, as part of a multi-institution research team, received $4.8 million in life science funding from the National Cancer Institute as part of a five-year life science grant to research a way to target various diseases including Alzheimer’s, cancer and graft-versus-host disease (GVHD) by changing the function of an enzyme that sets in motion over 100 different protein substrates in the body.
Researchers at Harvard University have recently published the results of a human clinical trial of a therapeutic that could increase the chances of success for blood stem cell transplantation. This will be the first time that the Harvard Stem Cell Institute has brought a discovery from the lab through clinical trials, marking the success of Harvard’s nine year-old goal of conducting groundbreaking research through the institute.
Researchers at Harvard University’s Wyss Institute for Biologically Inspired Engineering recently received $3.5 million in life science funding from the NIH. The grant is called a Transformative Research Award. The NIH’s aim in creating this grant is to fund high-risk, high-reward research. According to News Medical, the NIH funded only 10 of these projects in 2013, one of which is Harvard University’s DNA-based microscopy method of viewing cells.
In an article on our Science Market Update blog last week, we featured some life science funding news stories that we covered in our Life Science Company and Industry News Briefs blog the week before. We’d like to do the same this week because a number of last week’s funding news stories may be of interest to lab suppliers working to sell lab equipment at these well-funded research institutions. In the following paragraphs, we’ll give a brief summary of what schools received funding, how much funding they received, and what the topic of research is. We’ll also include links for further reading.
Tags: 2014, Emory University, Harvard University, Pennsylvania, Northeast, University of Pennsylvania, UPenn, University of North Carolina at Chapel Hill, Duke University, North Carolina, University of North Carolina, Life Science Funding, Southern, Georgia, Massachusetts, Boston, Philadelphia, Emory, BioResearch Product Faire Event, Durham, Harvard, Atlanta, Front Line, Chapel Hill, Duke, UNC
Reading our Science Market Update blog is a great way to stay informed of industry trends and research, funding and life science building news, but did you know that there is also a great deal of funding and life science market news available on our company news blog? We have put together a list, including links to the articles, of some recent news posted on our Life Science Company and Industry News Briefs blog available to life science sales and marketing professionals interested in staying informed of life science marketing and industry news.
Tags: 2014, University of California Los Angeles, Harvard University, Rockefeller University, University of Arizona, University of Pittsburgh, Pennsylvania, Northeast, University of Pennsylvania, UPenn, New York, UPITT, Southwest, California, Los Angeles, Alabama, University of Alabama, Southern, Massachusetts, Life Science Company and Industry News Briefs, Arizona, Boston, LAVS, Philadelphia, UAZ, RockU, BioResearch Product Faire Event, UAlab, Harvard, Birmingham, Front Line, Tucson, Pittsburgh, Stony Brook, industry news, funding news, Science Market Update, Science Researcher Update, NIH grants, life science events, SunySB
Science researchers at Harvard University have discovered a gene found in the most devastating forms of cancer that controls embryonic stem cell self-renewal. The gene, SALL4, enables stem cells to keep dividing rather than grow into mature cells. The gene is re-expressed in almost all cases of acute myeloid leukemia and between 10 to 30 percent of lung, ovarian, gastric, liver, breast and endometrial cancer. Researchers say they can make a strong case that the gene plays a part in tumor formation. The breakthrough marks the beginning of a search for a drug that can block the gene’s activity.
It is implicit that marketing life science solutions at a high quality life science marketing vendor show in Boston will result in excellent biotech sales leads, especially when one takes into account The Boston Globe’s recent report on the biotech industry boom in Boston. At least nine life science companies in Massachusetts could go public this year, making the boom one of the biggest since 2007.
The Massachusetts Life Sciences Center recently announced that it will be giving $9 million in grants to Harvard Medical School and Boston Children’s Hospital to update research labs. Harvard Medical School will be receiving $5 million of the money and plans to use the research funding to create a Laboratory of Systems Pharmacology, which will be multidisciplinary in nature and will help to supply better information on clinical trials while drugs are in the process of development. Boston Children's Hospital will use the $4 million it receives from the state to establish the Children’s Center for Cell Therapy, which will include renovating labs to create specialized stem cell culturing facilities.
Tags: 2014, Harvard University, 2013, Northeast, Life Science Funding, Massachusetts, Boston, BioResearch Product Faire Event, Research Funding, MA, Harvard, Harvard Medical School, life science marketing events, lab sales leads